Holly Vance SEC EDGAR Filings (CIK 0001827307)

SEC EDGAR filings, ownership reports, and insider transactions for Holly Vance.

Business address
C/O Neoleukin Therapeutics, Inc., 360 1616 Eastlake Avenue E., Seattle, WA, 98102
Get insider transactions for this reporting owner
Holly Vance has filed 3 SEC EDGAR filings since 20 Oct 2020

Latest Filings

Recent SEC filings for Holly Vance including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 05 Aug 2021 03 Aug 2021 001-36327
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 20 Oct 2020 19 Oct 2020 001-36327
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 20 Oct 2020 19 Oct 2020 001-36327

About this filer

Holly Vance files with the SEC under CIK 0001827307. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages